392.3 ð©º å §ç§å°ç§èåç
392.3.0.1 ð äžé éé»
- 22E updates:
- ICI-induced hypophysitis æ¥è¿ 5-10% with ipilimumab; mostly anterior; treatment å€ hormone replacement only (high-dose steroid äžå¿ in most)
- Macimorelin approved for adult GHD diagnosis (oral, easier than ITT)
- Long-acting GH (somapacitan, lonapegsomatropin) weekly dosing â simplifies adherence
- Long-acting hydrocortisone (Plenadren, Chronocort) trying to mimic circadian
- Taiwan: å¥ä¿ hydrocortisone, prednisone, dexamethasoneïŒäŸ conditionïŒ, levothyroxine, testosterone undecanoate, estradiol, somatropin, desmopressin
392.3.0.2 ð Pearls (15)
- ICI hypophysitis vs autoimmune lymphocytic hypophysitis: åè å€ åš ipi åŸ 6-12 é±; åŸè å€ women in pregnancy/postpartum
- ICI hypophysitis treatment: hormone replacement; high-dose steroid only if mass effect / vision (controversial; many resolve without)
- TBI screen: 30-50% have anterior pituitary dysfunction at 6-12 mo
- Pituitary apoplexy: occurs in 7-25% of macroadenomas; risk factors include anticoagulation, surgery, head trauma, pregnancy
- Sheehanâs å€åš developing countries due to obstetric care
- Lymphocytic hypophysitis can mimic adenoma; MRI shows thickened stalk + symmetric pituitary enlargement
- Cosyntropin 1 ÎŒg test: more sensitive (low-dose) but less validated; 250 ÎŒg standard
- Glucagon stim for combined GH + cortisol (when ITT contraindicated)
- Hypoadrenalism in pregnancy: HPA axis changes complicate diagnosis (CBG â); use total cortisol cutoffs higher
- Macimorelin oral GH stim: cutoff GH < 2.8 ng/mL (US), > 2.8 â not deficient
- Long-acting GH (somapacitan once weekly) approved adult GHD â improved adherence
- GH replacement caveats: monitor IGF-1, contraindicated in active CA, severe DR, ICH
- Hydrocortisone replacement mimicking circadian: AM 10-15 mg, midday 5-10 mg, evening 0-5 mg
- Plenadren / Chronocort: dual-release / chrono-release HC formulations; mimics circadian rhythm
- Stress dose practice: educate patient + emergency injection kit (HC 100 mg)
392.3.0.3 ð Taiwan + å¥ä¿
392.3.0.3.1 Replacement
- Hydrocortisone: å¥ä¿æïŒåé limitïŒprednisolone æ¿ä»£æ®å
- Levothyroxine: å¥ä¿
- Testosterone:
- Testosterone undecanoate (Nebido) IM q10-14 wk (å¥ä¿æ¢ä»¶)
- Topical gel (å¥ä¿æ¢ä»¶)
- Estrogen + progestin: HRT å¥ä¿æ¢ä»¶ (women)
- Somatropin: å¥ä¿å ç«¥; æäºº AGHD åŽæ Œæ¢ä»¶ (biochemical proof + symptoms)
- Desmopressin: å¥ä¿ central DI æ¢ä»¶
- Macimorelin: å¥ä¿æ¢ä»¶
392.3.0.4 ð å §å°å¿ æ (15)
- 8 倧åå + åç¹åŸµ
- Loss order + äŸå€
- æ¿ä»£é åº (cortisol æ°žé å )
- Stress dose å scenario
- Cosyntropin 250 vs 1 ÎŒg
- Sheehan + apoplexy + ICI hypophysitis ç¹åŸµ + æ¥æ§èç
- TBI screening + follow-up
- Genetic causes: PROP1, POU1F1, HESX1, TPIT, Kallmann
- GHD adult diagnosis: stim test (ITT/glucagon/macimorelin) + IGF-1
- GH replacement monitoring + contraindications
- Central hypothyroid: free T4 monitor (NOT TSH)
- Hypogonadotropic hypogonadism + fertility æ²»ç (gonadotropin vs pulsatile GnRH)
- 22E new drugs: macimorelin, somapacitan/lonapegsomatropin (long-acting GH), Plenadren/Chronocort (HC formulations)
- Pregnancy + replacement adjustments (cortisol, T4 dose â)
- Emergency injection kit + medical alert bracelet for cortisol-deficient patients
392.3.0.5 âïž Pituitary Apoplexy èç (å §å° detail)
1. ABCs + IV access
2. **Hydrocortisone 100 mg IV STAT** (don't wait for confirmation)
3. IV NS resuscitation
4. Emergent MRI sella
5. Ophthalmology + neurosurgery consult
6. Endocrinology axis assessment
7. Decision:
- Surgical decompression if visual deterioration / consciousness change
- Medical (steroid) if stable + no chiasm pressure
8. Long-term: 倿ž develop hypopituitarism; serial replacement
392.3.0.6 âïž ICI Hypophysitis èç (å §å° detail)
1. é«åºŠæ·ç: ipi recently (6-12 wk), fatigue/HA/N&V
2. æœè¡: ACTH/cortisol/TSH/free T4/LH/FSH/T or E2/PRL
3. MRI sella (mild enlargement / heterogeneous, often æ¹å)
4. ç«å³ hydrocortisone (replacement dose 15-25 mg/d, NOT high-dose)
- é«åé steroid (1-2 mg/kg pred) åªçšæŒ mass effect / vision (uncommon)
5. Levothyroxine if T4 low (cortisol first)
6. Testosterone / estrogen replacement
7. ICI äž stop in most cases (anterior axis éåžž permanent)
8. é·æ follow-up: å€ require lifelong replacement
392.3.0.7 âïž Acute Post-Op Cortisol Assessment
- Day 2-3 after pituitary surgery: AM cortisol
- > 15 â likely sufficient (consider stop replacement)
- < 5 â definite deficiency (continue replacement)
- 5-15 â equivocal; do stim test 4-6 wk later
- Cosyntropin stim 4-6 wk post-op more reliable (adrenal atrophic by then if ACTH chronic low)
â ïž AI èçš¿ã